Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 83 Letrozole 77 Paclitaxel 76 pembrolizumab 72 Specimen Handling 66 Trastuzumab 62 Carboplatin 57 Magnetic Resonance Spectroscopy 51 ribociclib 49 Capecitabine 48 Anastrozole 47 pertuzumab 46 palbociclib 43 exemestane 40 abemaciclib 40 Cyclophosphamide 40 Tamoxifen 39 Biopsy 38 Docetaxel 30 trastuzumab deruxtecan 29 Taxes 28 Radiotherapy 28 Gemcitabine 25 Blood Specimen Collection 25 130-nm albumin-bound paclitaxel 25 olaparib 22 Surveys and Questionnaires 22 Standard of Care 22 sacituzumab govitecan 20 eribulin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

EC regimen × Breast × 90 days × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡